Αποτελέσματα Αναζήτησης
1 Μαΐ 2018 · Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®) is a Chemotherapy Regimen for Breast Cancer - early stage. How does Dose-Dense AC + TH work? Doxorubicin, cyclophosphamide, and paclitaxel are designed to kill or slow the growth of cancer cells.
CANCER DRUG PHARMACOLOGY TABLE. Cytotoxic Chemotherapy. Drugs are classified according to the BC Cancer Drug Manual Monographs, unless otherwise specified (see asterisks). Subclassifications are in brackets where applicable.
AC chemotherapy can be used to treat primary breast cancer – breast cancer that hasn’t spread beyond the breast or the lymph nodes under the arm. Sometimes it’s used in combination with other anti-cancer drugs. Chemotherapy is given to reduce the risk of breast cancer returning or spreading.
14 Δεκ 2023 · Women with early-stage breast cancer that meet criteria for HER2 positivity are treated with chemotherapy and trastuzumab as adjuvant treatment. This topic review will cover the use of adjuvant HER2-directed therapy plus chemotherapy in patients with HER2-positive, early-stage breast cancer (stage I to III).
This treatment regimen consists of two parts: 4 cycles of AC, followed by 4 cycles of TH and 13 cycles of trastuzumab. Breast neoadjuvant/adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) three weekly. Breast adjuvant TH (DOCEtaxel and trastuzumab) three weekly.
When the older woman presents with early-stage breast cancer, the surgeon must evaluate the size and location of the cancer by physical exam and imaging and then determine the patient's general health status and life expectancy.
Adjuvant chemotherapy regimen selection in HER2-positive disease is certainly different story. Like in HER2-negative cases, a classical sequential chemotherapy as AC followed by weekly paclitaxel, combined for this purpose with trastuzumab, could be a good treatment choice for certain patients.
